Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Solal-Celigny

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Presse Medicale (Paris, France : 1983)|June 14, 1986
[Interstitial lymphoid pneumonia and polyadenopathies in patients infected with the LAV/HTLV III virus]L J Couderc, P Hervé, P Solal-Celigny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with responseJ M Foran, D Cunningham, B Coiffier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'AdulteB Coiffier, E M Neidhardt-Bérard, H Tilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2005
Meta-analysis to evaluate the role of interferon in follicular lymphomaA Z S Rohatiner, W M Gregory, B Peterson, et al.
Bone Marrow Transplantation|March 15, 2005
rHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot studyM Hunault-Berger, A Tanguy-Schmidt, P Rachieru, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2010
18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS groupX Cahu, C Bodet-Milin, E Brissot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'AdulteP Feugier, A Van Hoof, C Sebban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2012
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-upP Colombat, N Brousse, G Salles, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatmentJ Bienvenu, R Chvetzoff, G Salles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature reviewG Damaj, V Verkarre, A Delmer, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Presse Medicale (Paris, France : 1983)|June 14, 1986
[Interstitial lymphoid pneumonia and polyadenopathies in patients infected with the LAV/HTLV III virus]L J Couderc, P Hervé, P Solal-Celigny, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with responseJ M Foran, D Cunningham, B Coiffier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'AdulteB Coiffier, E M Neidhardt-Bérard, H Tilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2005
Meta-analysis to evaluate the role of interferon in follicular lymphomaA Z S Rohatiner, W M Gregory, B Peterson, et al.
Bone Marrow Transplantation|March 15, 2005
rHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot studyM Hunault-Berger, A Tanguy-Schmidt, P Rachieru, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2010
18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS groupX Cahu, C Bodet-Milin, E Brissot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'AdulteP Feugier, A Van Hoof, C Sebban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2012
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-upP Colombat, N Brousse, G Salles, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatmentJ Bienvenu, R Chvetzoff, G Salles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature reviewG Damaj, V Verkarre, A Delmer, et al.
Pageof 7